The largest database of trusted experimental protocols

Xbridge c18 column

Manufactured by Shimadzu
Sourced in Japan

The XBridge® C18 column is a high-performance liquid chromatography (HPLC) column designed for the separation and analysis of a wide range of compounds. It features a durable silica-based packing material with a stable C18 bonded phase, providing efficient and reproducible separations.

Automatically generated - may contain errors

5 protocols using xbridge c18 column

1

Quantitative HPLC Analysis of EXD Extract

Check if the same lab product or an alternative is used in the 5 most similar protocols
The analysis of the constituents was performed on an Agilent HPLC (1260 infinity) equipped with a diode array detector (1260 variable wavelength detector) with an XBridge® C18 column (5 μm, 150 mm × 4.6 mm i.d., Shimadzu, JPN). The chromatographic separations were carried out on a mobile phase consisting of 0.1% acetic acid (A) and acetonitrile (B) using a gradient programmes of 5–5% (B) in 0–15 min, 5–20% (B) in 15–20 min, 20–40% (B) in 20–35 min and 40–50% (B) in 35–60 min at a flow rate of 1.0 mL/min and column temperature of 25 °C. The injection volume was 10 μL, and the UV detection wavelength was 351 nm.
The EXD extract (0.1 g) was placed in a volumetric flask with 10.0 mL of 95% methanol at 60 °C for 2 h, during which the mixture was subjected to ultra-sonication for 15 min twice. Authentic samples were prepared in methanol solution (1.0 mg/mL). All the samples were filtered through a 0.22 μm filter (Millipore) before they were injected into the HPLC. Peaks were confirmed using the UV absorption and retention times of the authentic samples.
+ Open protocol
+ Expand
2

HPLC Quantification of Acetaminophen and Griseofulvin

Check if the same lab product or an alternative is used in the 5 most similar protocols
A Shimadzu HPLC system (Shimadzu Corporation, Kyoto, Japan) equipped with an XBridge C18 column (3.5 μM, 4.6 × 150 mm) was used to quantify the acetaminophen and griseofulvin samples.
For acetaminophen samples, 20 μL was injected and detected at 275 nm. The mobile phase containing 69% of water, 3% of acetic acid, and 28% of methanol (v/v) was kept at a constant flow rate of 0.8 mL/min. The column chamber temperature was set at 27 °C and the detector chamber temperature was maintained at 40 °C. For griseofulvin samples, 20 μL was injected and detected at 291 nm. The mobile phase containing 35% of water with 0.1% of trifluoroacetic acid and 65% of acetonitrile (v/v) was kept at a constant flow rate of 1 mL/min. The temperature of both the column chamber and the detector chamber was kept at 40 °C.
+ Open protocol
+ Expand
3

Comprehensive LC-MS/MS Analysis of Paclitaxel and Doxorubicin

Check if the same lab product or an alternative is used in the 5 most similar protocols
The total drug is measured in our study including released and unreleased drug, as well as protein bound drug in plasma to illustrate the questions below, unlike other studies provided the detail analysis of three different types of drugs [51 (link),52 ], The LC-MS/MS analysis of paclitaxel was performed using docetaxel as internal standard (IS). LC-MS/MS analysis of doxorubicin was performed using daunarubicin as internal standard (IS). The analytical assay was validated according FDA guidance for linearity (2–5000 ng/mL), matrix effect, recovery, low detection limit, Quality control (QC) in different biological matrix, including plasma, blood, tumor, and each different organ homogenates. LC-MS/MS was performed using ABI-5500 Qtrap (Sciex, Ontario, Canada) mass spectrometer with electrospray ionization source was interfaced with Shimadzu high performance liquid chromatography (HPLC) system with Xbridge C18 column (50 × 2.1 mm ID, 3.5 μm). The mass spectrometer was operated in a positive mode with multiple reaction monitoring (MRM) for analysis. The MRM transitions were monitored at m/z 854.4 to 286.1 for paclitaxel and m/z 808.0 to 226.0 for internal standard. The MRM transitions were monitored at m/z 544.1 to 397.2 for doxorubicin and m/z 528.5 to 321 for internal standard.
+ Open protocol
+ Expand
4

Quantification of Pharmaceuticals by UPLC-MS/MS

Check if the same lab product or an alternative is used in the 5 most similar protocols
For HPLC, System: Waters Acquity UPLC H-Class (UFLC Nexera, SHIMADZU, Kyoto, Japan); Chromatographic column: X Bridge C18 column (2.5 μm, 2.1 mm × 75 mm); column temperature: 30 °C; sample chamber temperature: 4 °C; injection volume 1 μL was used for accomplishing the chromatographic separation with mobile phase consisting of A: 0.1% formic acid water B: methanol.
In a positive ion mode, an API 4000 triple quadrupole tandem mass spectrometer (SCIEX, Framingham, MA, USA) with an ESI (AB SCIEX, Framingham, MA, USA) source was used, and the acquisition and analysis of data were carried out with Analyst 1.6.2 software (Applied Biosystems, Foster City, CA, USA). Multiple reaction monitoring (MRM) parameters for the ganciclovir, cimetidine, digoxin and ebesartan (internal standard, IS) were optimized and are summarized in Table S3. The other ionization parameters were as follows: curtain gas, 20 psi; collision gas, 6 psi; ion source gas 1, 50 psi; ion source gas 2, 50 psi, respectively, with a temperature of 500 °C and an ion spray needle voltage of 5500 V The bioanalytical method validation guidance for industry released by the FDA in 2018 was used to validate the analytical approach used in this study. The selectivity, specificity, accuracy, matrix effects, stability, served as key metrics to affirm the validity of this method [40 (link)].
+ Open protocol
+ Expand
5

HPLC Quantification of Griseofulvin

Check if the same lab product or an alternative is used in the 5 most similar protocols
Griseofulvin concentration was quantified using a Shimadzu HPLC system (Shimadzu Corporation, Kyoto, Japan) installed with an XBridge C18 column (3.5 μm, 4.6 mm × 150 mm) at 291 nm UV detection wavelength. The mobile phase consisted of 35% (v/v) of 0.1% trifluoroacetic acid in water (mobile phase A) and 65% (v/v) of acetonitrile (mobile phase B). The flow rate was kept at 1 mL/min. Both the column chamber and the detector chamber were maintained at 40 °C.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!